Lin Hao
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism 6
-
- Lung Cancer Diagnosis and Treatment 13
- Ferroptosis and cancer prognosis 7
- Gastric Cancer Management and Outcomes 6
- Urology top 10%
- Urological Disorders and Treatments 6
-
- Epigenetics and DNA Methylation 6
-
- Bladder and Urothelial Cancer Treatments 17
-
- Urologic and reproductive health conditions 5
Lin Hao
75 papers receiving 981 citations
Peers
Comparison fields: 5 of 99
- Cancer Research 187
- Pulmonary and Respiratory Medicine 340
- Oncology 195
- Urology 36
- Molecular Biology 384
Countries citing papers authored by Lin Hao
This map shows the geographic impact of Lin Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Hao more than expected).
Fields of papers citing papers by Lin Hao
This network shows the impact of papers produced by Lin Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Hao. The network helps show where Lin Hao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lin Hao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 23 | |
| 4 | 2023 | 3 | |
| 5 | 2022 | 19 | |
| 6 | 2022 | 77 | |
| 7 | 2022 | 0 | |
| 8 | 2022 | 9 | |
| 9 | 2021 | 21 | |
| 10 | 2021 | 17 | |
| 11 | 2021 | 7 | |
| 12 | 2020 | 9 | |
| 13 | 2019 | 3 | |
| 14 | 2019 | 19 | |
| 15 | 2019 | 0 | |
| 16 | 2014 | 9 | |
| 17 | 2014 | 2 | |
| 18 | 2013 | 15 | |
| 19 | 2009 | 1 | |
| 20 | 2009 | 1 |
About Lin Hao
Lin Hao is a scholar working on Urology, Cancer Research, Pulmonary and Respiratory Medicine, Rheumatology and Surgery, having authored 80 papers that have together received 997 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (17 papers), Lung Cancer Diagnosis and Treatment (13 papers), Ferroptosis and cancer prognosis (7 papers), Gastric Cancer Management and Outcomes (6 papers), Urological Disorders and Treatments (6 papers), Epigenetics and DNA Methylation (6 papers), Cancer, Lipids, and Metabolism (6 papers) and Urologic and reproductive health conditions (5 papers). The work is most often cited by research in Cancer Research (187 citations), Pulmonary and Respiratory Medicine (340 citations), Oncology (195 citations), Urology (36 citations) and Molecular Biology (384 citations). Lin Hao has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Conghui Han, Qingquan Luo, Zhenduo Shi, Guanghui Zang, Kun Pang, Yang Dong, Jingwei Jiang, Xiaohua Liang, Jia Huang and Xinli Zhou. Their work appears in journals such as Translational Lung Cancer Research, Cell Biochemistry and Biophysics, Frontiers in Oncology, Clinical & Translational Oncology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.